Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Is Top International Priority For AdvaMed's New Chairman

This article was originally published in PharmAsia News

Executive Summary

U.S. medical device association AdvaMed's new chairman, Jim Mazzo, cites regulatory roadblocks in China as the most important international marketing issue facing U.S. device manufacturers

You may also be interested in...



AdvaMed's Next Chairman Is Abbott Exec Jim Mazzo

Abbott Medical Optics' chief exec Jim Mazzo is on deck to be the next chairman of AdvaMed, succeeding the outgoing Michael Mussallem

Japan Rolls Out Three-Tiered Review System For Medical Devices

Japan is rolling out a new three-track medical device review system based on the novelty of the product, Japanese device reviewers said last week

U.S.-China Device Talks Yield Some Concessions, But Big Issues Unresolved

A recent meeting between U.S. and Chinese government officials and device industry reps yielded some concessions to opening up China's market, but left many more issues on the table, according to a U.S. industry participant

Related Content

UsernamePublicRestriction

Register

SC074221

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel